These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11742874)

  • 1. Identification of differentially regulated genes in mildly hyperlipidemic ApoE3-Leiden mice by use of serial analysis of gene expression.
    Kreeft AJ; Moen CJ; Hofker MH; Frants RR; Vreugdenhil E; Gijbels MJ; Havekes LM; Datson NA
    Arterioscler Thromb Vasc Biol; 2001 Dec; 21(12):1984-90. PubMed ID: 11742874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic analysis of the response of mouse models to high-fat feeding shows a major role of nuclear receptors in the simultaneous regulation of lipid and inflammatory genes.
    Kreeft AJ; Moen CJ; Porter G; Kasanmoentalib S; Sverdlov R; van Gorp PJ; Havekes LM; Frants RR; Hofker MH
    Atherosclerosis; 2005 Oct; 182(2):249-57. PubMed ID: 16159597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of hypercholesterolemia in apolipoprotein E2 and apolipoprotein E3-Leiden transgenic mice by adenovirus-mediated gene transfer of the VLDL receptor.
    van Dijk KW; van Vlijmen BJ; van der Zee A; van't Hof B; van der Boom H; Kobayashi K; Chan L; Havekes LM; Hofker MH
    Arterioscler Thromb Vasc Biol; 1998 Jan; 18(1):7-12. PubMed ID: 9445249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic lipid accumulation, altered very low density lipoprotein formation and apolipoprotein E deposition in apolipoprotein E3-Leiden transgenic mice.
    Mensenkamp AR; van Luyn MJ; van Goor H; Bloks V; Apostel F; Greeve J; Hofker MH; Jong MC; van Vlijmen BJ; Havekes LM; Kuipers F
    J Hepatol; 2000 Aug; 33(2):189-98. PubMed ID: 10952236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative assessment of aortic atherosclerosis in APOE*3 Leiden transgenic mice and its relationship to serum cholesterol exposure.
    Groot PH; van Vlijmen BJ; Benson GM; Hofker MH; Schiffelers R; Vidgeon-Hart M; Havekes LM
    Arterioscler Thromb Vasc Biol; 1996 Aug; 16(8):926-33. PubMed ID: 8696955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of atherosclerotic lesions in apo E3-leiden transgenic mice.
    Leppänen P; Luoma JS; Hofker MH; Havekes LM; Ylä-Herttuala S
    Atherosclerosis; 1998 Jan; 136(1):147-52. PubMed ID: 9544741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No effect of C-reactive protein on early atherosclerosis development in apolipoprotein E*3-leiden/human C-reactive protein transgenic mice.
    Trion A; de Maat MP; Jukema JW; van der Laarse A; Maas MC; Offerman EH; Havekes LM; Szalai AJ; Princen HM; Emeis JJ
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1635-40. PubMed ID: 15920036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of macrophage-derived mouse ApoE, human ApoE3-Leiden, and human ApoE2 (Arg158-->Cys) on cholesterol levels and atherosclerosis in ApoE-deficient mice.
    Van Eck M; Herijgers N; Van Dijk KW; Havekes LM; Hofker MH; Groot PH; Van Berkel TJ
    Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):119-27. PubMed ID: 10634808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic deletion of tissue-type plasminogen activator (t-PA) in APOE3-Leiden mice reduces progression of cholesterol-induced atherosclerosis.
    Rezaee F; Gijbels M; Offerman E; Verheijen J
    Thromb Haemost; 2003 Oct; 90(4):710-6. PubMed ID: 14515193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The amino-terminal 1-185 domain of apoE promotes the clearance of lipoprotein remnants in vivo. The carboxy-terminal domain is required for induction of hyperlipidemia in normal and apoE-deficient mice.
    Kypreos KE; Morani P; van Dijk KW; Havekes LM; Zannis VI
    Biochemistry; 2001 May; 40(20):6027-35. PubMed ID: 11352738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of human apolipoprotein A-I/C-III/A-IV gene cluster in mice induces hyperlipidemia but reduces atherogenesis.
    Vergnes L; Baroukh N; Ostos MA; Castro G; Duverger N; Nanjee MN; Najib J; Fruchart JC; Miller NE; Zakin MM; Ochoa A
    Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):2267-74. PubMed ID: 11031214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of pathways for atherosclerosis in mice: integration of quantitative trait locus analysis and global gene expression data.
    Wang SS; Schadt EE; Wang H; Wang X; Ingram-Drake L; Shi W; Drake TA; Lusis AJ
    Circ Res; 2007 Aug; 101(3):e11-30. PubMed ID: 17641228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperlipidemia of ApoE2(Arg(158)-Cys) and ApoE3-Leiden transgenic mice is modulated predominantly by LDL receptor expression.
    van Dijk KW; van Vlijmen BJ; de Winther MP; van 't Hof B; van der Zee A; van der Boom H; Havekes LM; Hofker MH
    Arterioscler Thromb Vasc Biol; 1999 Dec; 19(12):2945-51. PubMed ID: 10591674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholesteryl ester transfer protein decreases high-density lipoprotein and severely aggravates atherosclerosis in APOE*3-Leiden mice.
    Westerterp M; van der Hoogt CC; de Haan W; Offerman EH; Dallinga-Thie GM; Jukema JW; Havekes LM; Rensen PC
    Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2552-9. PubMed ID: 16946130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice.
    van Vlijmen BJ; van den Maagdenberg AM; Gijbels MJ; van der Boom H; HogenEsch H; Frants RR; Hofker MH; Havekes LM
    J Clin Invest; 1994 Apr; 93(4):1403-10. PubMed ID: 8163645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scavenger receptor deficiency leads to more complex atherosclerotic lesions in APOE3Leiden transgenic mice.
    de Winther MP; Gijbels MJ; van Dijk KW; van Gorp PJ; suzuki H; Kodama T; Frants RR; Havekes LM; Hofker MH
    Atherosclerosis; 1999 Jun; 144(2):315-21. PubMed ID: 10407492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cafestol increases serum cholesterol levels in apolipoprotein E*3-Leiden transgenic mice by suppression of bile acid synthesis.
    Post SM; de Roos B; Vermeulen M; Afman L; Jong MC; Dahlmans VE; Havekes LM; Stellaard F; Katan MB; Princen HM
    Arterioscler Thromb Vasc Biol; 2000 Jun; 20(6):1551-6. PubMed ID: 10845871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atorvastatin increases HDL cholesterol by reducing CETP expression in cholesterol-fed APOE*3-Leiden.CETP mice.
    de Haan W; van der Hoogt CC; Westerterp M; Hoekstra M; Dallinga-Thie GM; Princen HM; Romijn JA; Jukema JW; Havekes LM; Rensen PC
    Atherosclerosis; 2008 Mar; 197(1):57-63. PubMed ID: 17868678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Both lipolysis and hepatic uptake of VLDL are impaired in transgenic mice coexpressing human apolipoprotein E*3Leiden and human apolipoprotein C1.
    Jong MC; Dahlmans VE; van Gorp PJ; Breuer ML; Mol MJ; van der Zee A; Frants RR; Hofker MH; Havekes LM
    Arterioscler Thromb Vasc Biol; 1996 Aug; 16(8):934-40. PubMed ID: 8696956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression and regression of atherosclerosis in APOE3-Leiden transgenic mice: an immunohistochemical study.
    Gijbels MJ; van der Cammen M; van der Laan LJ; Emeis JJ; Havekes LM; Hofker MH; Kraal G
    Atherosclerosis; 1999 Mar; 143(1):15-25. PubMed ID: 10208477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.